Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. K.C. Pharmaceuticals, Inc
FDA Inspection
•K.C. Pharmaceuticals, Inc•February 13, 2026

K.C. Pharmaceuticals, Inc – FDA Inspection, Feb 13, 2026

Record Details

This FDA Inspection record concerns K.C. Pharmaceuticals, Inc, with an inspection on February 13, 2026, issued by the Los Angeles District Office, covering human drugs.

Company
K.C. Pharmaceuticals, Inc
Inspection Date
February 13, 2026
Product Type
Human Drugs
Office
Los Angeles District Office
People
  • Crystal Monroy
  • Luis F. Torres (Issuing Officer)
  • Luis P. Torres (Issuing Officer)
  • Nathan E. Hellman (Issuing Officer)
  • Ngozi G. Offor (Company Rep)
  • Pearl C. Ozuruigbo (Investigator)
  • Rowena S. Nguyen (Issuing Officer)
  • Truong X. Nguyen (FDA Associated Person)
  • Walden H. Lee (FDA Associated Person)
View Company Profile

ID · cd0d8819-eb97-4026-b57a-60b8938692d8

Inspection Facts

Inspection number
1294070
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

13
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.113(b)Validation lacking for sterile drug products
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.165(e)Test methods
  5. 21 CFR 211.166(a)(3)Valid stability test methods
  6. 21 CFR 211.188Prepared for each batch, include complete information
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.198(a)Procedures to be written and followed
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed
  10. 21 CFR 211.42(c)(10)Aseptic Processing Area

Showing 10 of 13 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of K.C. Pharmaceuticals, Inc

10
DateClassificationOfficeProject area
August 28, 2024VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 13, 2023OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 30, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 16, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 19, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for K.C. Pharmaceuticals, Inc
  • FDA Inspection 1247201 - 2024-08-28
  • FDA Inspection 1197242 - 2023-02-13
  • FDA Inspection 1116341 - 2020-01-30
  • FDA Inspection 1032267 - 2017-11-16
  • FDA Inspection 923526 - 2015-03-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore K.C. Pharmaceuticals, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.